Objectives Some large population-based studies have reported a dose-related increased
risk of cataracts and glaucoma associated with use of inhaled corticosteroids (ICS) in …

Background and objective: The risk of cataracts associated with the long‐term use of inhaled
corticosteroids (ICS) is poorly recognized, yet may be of major public health importance. The …

Purpose: Exposure to corticosteroids is known to be associated with an increased risk of
cataract and glaucoma. This study was undertaken to determine the prevalence of steroid …

Purpose. Both systemic and inhaled corticosteroids may increase the risk of cataract in
patients with both chronic obstructive pulmonary disease (COPD) and asthma. Our aim was …

Orally inhaled corticosteroid use has been convincingly linked to an increase in the risk of
cataracts, although the risk at lower doses in common use remains uncertain. The potential …

Prolonged exposure to inhaled corticosteroids among adults over 49 years old has been
reported to increase cataract risk. Small-scale studies of inhaled steroid users suggest that …

Background/aims: Exposure to systemic corticosteroid use is known to be associated with a
risk of cataract. Whether low doses of inhaled corticosteroids are associated with an …

Purpose Starting in 2019, the Global Initiative for Asthma recommended the use of inhaled
corticosteroids (ICS) as part of reliever combination therapy in patients 12 years of age and …

BACKGROUND: Topical and systemic corticosteroids are well known to raise intra-ocular
pressure while the effect of inhaled corticosteroids (ICS) on the risk of glaucoma remains …

Background To evaluate the adverse events profile of oral prednisolone among adult
asthma patients in the UK. Methods Using data from the UK-based Clinical Practice …